Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 32 member E, pseudogene (FAM32EP) is classified as a pseudogene, meaning it is a DNA sequence similar to a functional gene but lacks the capacity to encode a functional protein[1][5]. Most pseudogenes are considered non-functional remnants of evolution. In rare cases, some pseudogenes may act as decoys for microRNAs or have regulatory roles at the RNA level[3], but there is currently no evidence that FAM32EP is functional or involved in any known biological process, disease, or drug interaction. Summary: - FAM32EP does not encode a protein or serve as a known receptor, enzyme, transporter, or other therapeutic target[5]. - It is best classified as a genomic pseudogene, not as a functional target for drugs or biomarkers. - The abbreviated target name is correct, but this is not a standard therapeutic or biologically significant target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 32 member E, pseudogene (FAM32EP).